{"id":"https://openalex.org/W2014464860","doi":"https://doi.org/10.1007/pl00005092","title":"Evaluation of the effects of a specific \u03b12-adrenoceptor antagonist, atipamezole, on \u03b11- and \u03b12-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine","display_name":"Evaluation of the effects of a specific \u03b12-adrenoceptor antagonist, atipamezole, on \u03b11- and \u03b12-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine","publication_year":1997,"publication_date":"1997-10-28","ids":{"openalex":"https://openalex.org/W2014464860","doi":"https://doi.org/10.1007/pl00005092","mag":"2014464860","pmid":"https://pubmed.ncbi.nlm.nih.gov/9402036"},"language":"en","primary_location":{"id":"doi:10.1007/pl00005092","doi":"https://doi.org/10.1007/pl00005092","is_oa":false,"landing_page_url":"https://doi.org/10.1007/pl00005092","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027596381","display_name":"Antti Haapalinna","orcid":"https://orcid.org/0000-0002-1179-6898","observed_orcids":["https://orcid.org/0000-0002-1179-6898"]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Antti Haapalinna","raw_affiliation_strings":["Orion Corporation, Orion Pharma, Turku, Finland","Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation, Orion Pharma, Turku, Finland","institution_ids":["https://openalex.org/I4210118237"]},{"raw_affiliation_string":"Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075480751","display_name":"Timo Viitamaa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Timo Viitamaa","raw_affiliation_strings":["Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022252286","display_name":"Ewen MacDonald","orcid":"https://orcid.org/0009-0002-6396-2680","observed_orcids":["https://orcid.org/0009-0002-6396-2680"]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Ewen MacDonald","raw_affiliation_strings":["Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1270, FIN-70211 Kuopio, Finland, FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1270, FIN-70211 Kuopio, Finland, FI","institution_ids":["https://openalex.org/I175532246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024659043","display_name":"Juha\u2010Matti Savola","orcid":"https://orcid.org/0000-0001-6208-0841","observed_orcids":["https://orcid.org/0000-0001-6208-0841"]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Juha-Matti Savola","raw_affiliation_strings":["Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037591874","display_name":"Leena M. Tuomisto","orcid":"https://orcid.org/0000-0002-5996-4782","observed_orcids":["https://orcid.org/0000-0002-5996-4782"]},"institutions":[{"id":"https://openalex.org/I175532246","display_name":"University of Eastern Finland","ror":"https://ror.org/00cyydd11","country_code":"FI","type":"education","lineage":["https://openalex.org/I175532246"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Leena Tuomisto","raw_affiliation_strings":["Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1270, FIN-70211 Kuopio, Finland, FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, University of Kuopio, P.O. Box 1270, FIN-70211 Kuopio, Finland, FI","institution_ids":["https://openalex.org/I175532246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111655171","display_name":"Raimo Virtanen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Raimo Virtanen","raw_affiliation_strings":["Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111579543","display_name":"Esa H. Heinonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Esa Heinonen","raw_affiliation_strings":["Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Corporation, Orion Pharma, P.O. Box 425,  FIN-20101 Turku, Finland, , FI","institution_ids":["https://openalex.org/I4210118237"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.8635,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.85393337,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"356","issue":"5","first_page":"570","last_page":"582"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5220000147819519,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.39160001277923584,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.06889999657869339,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atipamezole","display_name":"atipamezole","score":0.9950000047683716},{"id":"https://openalex.org/keywords/yohimbine","display_name":"yohimbine","score":1.0},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-antagonists","display_name":"alpha2-adrenoceptor antagonists","score":0.8840000033378601},{"id":"https://openalex.org/keywords/alpha1-adrenergic-receptors","display_name":"alpha1-adrenoceptors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/alpha2-adrenoceptor-subtypes","display_name":"alpha2-adrenoceptor subtypes","score":0.9160000085830688},{"id":"https://openalex.org/keywords/noradrenaline-turnover","display_name":"noradrenaline turnover","score":0.7960000038146973},{"id":"https://openalex.org/keywords/dopamine-turnover","display_name":"dopamine turnover","score":0.7900000214576721},{"id":"https://openalex.org/keywords/serotonin-turnover","display_name":"serotonin turnover","score":0.9399999976158142},{"id":"https://openalex.org/keywords/pupil-dilation","display_name":"pupil dilation","score":0.718999981880188},{"id":"https://openalex.org/keywords/medetomidine","display_name":"medetomidine","score":0.8009999990463257},{"id":"https://openalex.org/keywords/food-reward","display_name":"food reward","score":0.4729999899864197},{"id":"https://openalex.org/keywords/neophobia","display_name":"neophobia","score":0.7720000147819519},{"id":"https://openalex.org/keywords/exploratory-behavior","display_name":"exploratory behavior","score":0.9599999785423279},{"id":"https://openalex.org/keywords/behavioral-pharmacology","display_name":"behavioral pharmacology","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C2777676773","wikidata":"https://www.wikidata.org/wiki/Q412226","display_name":"Yohimbine","level":4,"score":0.9699298143386841},{"id":"https://openalex.org/C2776312488","wikidata":"https://www.wikidata.org/wiki/Q413894","display_name":"Atipamezole","level":5,"score":0.9163640737533569},{"id":"https://openalex.org/C13348194","wikidata":"https://www.wikidata.org/wiki/Q288084","display_name":"Alpha-2 adrenergic receptor","level":3,"score":0.6849184632301331},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5457366108894348},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5383108854293823},{"id":"https://openalex.org/C2780648677","wikidata":"https://www.wikidata.org/wiki/Q425296","display_name":"Prazosin","level":4,"score":0.5165997743606567},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4781392812728882},{"id":"https://openalex.org/C2780939551","wikidata":"https://www.wikidata.org/wiki/Q5987770","display_name":"Idazoxan","level":5,"score":0.4720778465270996},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.47096139192581177},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4485102593898773},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.440765917301178},{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.43200886249542236},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42029261589050293},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38598746061325073},{"id":"https://openalex.org/C2779520467","wikidata":"https://www.wikidata.org/wiki/Q427179","display_name":"Medetomidine","level":4,"score":0.342816025018692},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3336811065673828},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24791452288627625},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14523842930793762},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001679","descriptor_name":"Biogenic Amines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011224","descriptor_name":"Prazosin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011942","descriptor_name":"Receptors, Adrenergic, alpha","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015016","descriptor_name":"Yohimbine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020926","descriptor_name":"Medetomidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/pl00005092","doi":"https://doi.org/10.1007/pl00005092","is_oa":false,"landing_page_url":"https://doi.org/10.1007/pl00005092","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:9402036","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9402036","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W95063195","https://openalex.org/W1535038405","https://openalex.org/W1966385194","https://openalex.org/W1966609551","https://openalex.org/W1975627286","https://openalex.org/W1986647402","https://openalex.org/W1989763616","https://openalex.org/W1991611883","https://openalex.org/W1992827863","https://openalex.org/W1993317618","https://openalex.org/W1999068708","https://openalex.org/W2002601777","https://openalex.org/W2009056197","https://openalex.org/W2009717522","https://openalex.org/W2013082402","https://openalex.org/W2017775996","https://openalex.org/W2019070756","https://openalex.org/W2019237255","https://openalex.org/W2030087674","https://openalex.org/W2030451134","https://openalex.org/W2030694155","https://openalex.org/W2033950872","https://openalex.org/W2038283049","https://openalex.org/W2040023751","https://openalex.org/W2040657792","https://openalex.org/W2042468643","https://openalex.org/W2051470375","https://openalex.org/W2052325698","https://openalex.org/W2056726838","https://openalex.org/W2060910799","https://openalex.org/W2061776529","https://openalex.org/W2072274697","https://openalex.org/W2075097976","https://openalex.org/W2077461364","https://openalex.org/W2080127546","https://openalex.org/W2080202671","https://openalex.org/W2081621943","https://openalex.org/W2087296926","https://openalex.org/W2091945604","https://openalex.org/W2103928294","https://openalex.org/W2112360126","https://openalex.org/W2128635872","https://openalex.org/W2142254783","https://openalex.org/W2252465426","https://openalex.org/W2259794087","https://openalex.org/W2268242404","https://openalex.org/W2303408262","https://openalex.org/W2395842141","https://openalex.org/W2414578283","https://openalex.org/W2474292363","https://openalex.org/W2913644113","https://openalex.org/W2916055452"],"related_works":["https://openalex.org/W2030087674","https://openalex.org/W2093214674","https://openalex.org/W2010353706","https://openalex.org/W2062822713","https://openalex.org/W2041421210","https://openalex.org/W2009580792","https://openalex.org/W2069333841","https://openalex.org/W2164362827","https://openalex.org/W2090860798","https://openalex.org/W95063195"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}